The purpose of the study is to determine in vitro effects on mitochondrial function of selected chemical agents in human cells, and assess the capability of a cell-permeable succinate prodrug to attenuate toxic effects The project aims at repurposing this recent pharmaceutical discovery, currently being developed for treatment of toxic exposure, for an expanded indication to treat chemically induced mitochondrial toxicity.
The study duration per subject will be approximately 15 minutes to complete the one time blood collection.
Study Type
OBSERVATIONAL
Enrollment
236
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Attenuation by the succinate prodrug of toxin-induced decrease in mitochondrial respiration.
Data will be assessed using 2-tailed Student's t-test. Dose-response curves for respiration will be made for each toxin and IC50 calculated. In case of difficulties in demonstrating acute toxicity of chemical agents, dose-titration experiments and long-term incubation (up to 24 hours) will be performed
Time frame: by end of 2018
Attenuation of toxin-induced decrease in mitochondrial membrane potential and attenuate lactate production by the succinate prodrug.
Data will be assessed using 2-tailed Student's t-test. Dose-response curves for respiration will be made for each toxin and IC50 calculated. In case of difficulties in demonstrating acute toxicity of chemical agents, dose-titration experiments and long-term incubation (up to 24 h) will be performed
Time frame: by end of 2018
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.